// App-Quantinova.ai

2061 : High-Dose Methotrexate Based Therapy for the Treatment of Bing Neel Syndrome

Researchers

Presenter

  • Suzanne O Arulogun

Principal Investigators

  • Michael P Lunn

  • Chandrashekar Hoskote

  • Aisling Carr

  • Oliver Tomkins

  • Ali Rismani

  • Ashutosh D. Wechalekar

  • Shirley D'Sa

Medical Centers

  • University College London Hospitals NHS Trust, London, United Kingdom

  • National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, United Kingdom

  • University College London and the Royal Free London NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cerebrospinal fluid

Drug/Treatment

  • Methotrexate

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A